Inositol, glycogen, insulin, and six Nobelists

Journal of Biological Chemistry

Volumn 288, Issue 17, 2013, Pages 12313-12324

  Larner, Joseph ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL CHEMISTRY; CHEMISTRY DEPARTMENTS; UNIVERSITY OF ILLINOIS; UNIVERSITY OF MICHIGAN; UNIVERSITY OF MINNESOTA; UNIVERSITY OF VIRGINIA; WASHINGTON UNIVERSITY; WESTERN RESERVE UNIVERSITY;

ALCOHOLS; BIOCHEMISTRY; EDUCATION; ENZYME ACTIVITY; INSULIN; POLYOLS; SUGARS;

IODINE;

ADRENALIN; ALKALINE PHOSPHATASE; EPIMERASE; GALACTOSAMINE; GLUCOSE; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; INOSITOL; INSULIN; PYRUVATE DEHYDROGENASE;

ADRENALIN RELEASE; ARTICLE; GLYCOGEN METABOLISM; GLYCOGEN STORAGE DISEASE; INSULIN RESISTANCE; KIDNEY TUBULE; MEDICAL SCHOOL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SPECTROPHOTOMETRY; UNITED STATES; URINARY EXCRETION;

GLYCOGEN; HISTORY, 20TH CENTURY; INOSITOL; INSULIN; NOBEL PRIZE;

RATTUS;

EID: 84876919340     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.X113.471177     Document Type: Article

References (65)

1. Larner, J., Jandorf, B. J., and Summerson, W. H. (1949) On the requirement for diphosphopyridine nucleotide in the aerobic metabolism of pyruvate by brain tissue. J. Biol. Chem. 178, 373-382
2. Woolley, D. W. (1940) The nature of the anti-alopecia factor. Science 92, 384-385
3. Cori, G. T., and Larner, J. (1951) Action of amylo-1, 6-glucosidase and phosphorylase on glycogen and amylopectin. J. Biol. Chem. 188, 17-29
4. Larner, J. (1953) The action of branching enzymes on outer chains of glycogen. J. Biol. Chem. 202, 491-503
5. Larner, J., Illingworth, B., Cori, G. T., and Cori, C. F. (1952) Structure of glycogens and amylopectins. II. Analysis by stepwise enzymatic degradation. J. Biol. Chem. 199, 641-651
6. Daughaday, W. H., and Larner, J. (1954) The renal excretion of inositol in normal and diabetic human beings. J. Clin. Invest. 33, 326-332
7. Daughaday, W. H., Larner, J., and Houghton, E. (1954) The renal excretion of inositol by normal and diabetic rats. J. Clin. Invest. 33, 1075-1080
8. Daughaday, W. H., Larner, J., and Hartnett, C. (1955) The synthesis of inositol in the immature rat and chick embryo. J. Biol. Chem. 212, 869-875
9. Larner, J., and McNickle, C. M. (1955) Gastrointestinal digestion of starch. I. The action of oligo-1, 6-glucosidase on branched saccharides. J. Biol. Chem. 215, 723-736
10. Larner, J., and Gillespie, R. E. (1955) Participation of histidine in catalytic activity of intestinal carbohydrases. Arch. Biochem. Biophys. 58, 252-253
11. Moscatelli, E. A., and Larner, J. (1959) The metabolism in the rat of photosynthetically prepared myo-inositol-C14. Arch. Biochem. Biophys. 80, 26-34
12. Larner, J., Jackson, W. T., Graves, D. J., and Stamer, J. R. (1956) Inositol dehydrogenase from Aerobacter aerogenes. Arch. Biochem. Biophys. 60, 352-363
13. Larner, J., Villar-Palasi, C., and Richman, D. J. (1960) Insulin-stimulated glycogen formation in rat diaphragm. Levels of tissue intermediates in short-time experiments. Arch. Biochem. Biophys. 86, 56-60
14. Villar-Palasi, C., and Larner, J. (1960) Uridinediphosphate glucose pyrophosphorylase from skeletal muscle. Arch. Biochem. Biophys. 86, 61-66
15. Villar-Palasi, C., and Larner, J. (1960) Levels of activity of the enzymes of the glycogen cycle in rat tissues. Arch. Biochem. Biophys. 86, 270-273
16. Larner, J., and Villar-Palasi, C. (1959) Enzymes in a glycogen storage myopathy. Proc. Natl. Acad. Sci. U. S. A. 45, 1234-1235
17. Larner, J. (1960) Genetic and hormonal control of glycogen metabolism. Fed. Proc. 19, 971-976
18. Villar-Palasi, C., and Larner, J. (1960) Insulin-mediated effect on the activity of UDPG-glycogen transglucosylase of muscle. Biochim. Biophys. Acta 39, 171-173
19. Craig, J. W., and Larner, J. (1964) Influence of epinephrine and insulin on uridine diphosphate glucose-a-glucan transferase and phosphorylase in muscle. Nature 202, 971-973
20. Friedman, D. L., and Larner, J. (1963) Studies on UDPG-a-glucan transglucosylase. III. Interconversion of two forms of muscle UDPG-a-glucan transglucosylase by a phosphorylation-dephosphorylation reaction sequence. Biochemistry 2, 669-675
21. Rosell-Perez, M., and Larner, J. (1964) Studies on UDPG-a-glucan transglucosylase. IV. Purification and characterization of two forms from rabbit skeletal muscle. Biochemistry 3, 75-81
22. Hizukuri, S., and Larner, J. (1964) Studies on UDPG-a-1, 4-glucan α-4-glucosyltransferase. VII. Conversion of the enzyme from glucose 6-phosphate-dependent to independent form in liver. Biochemistry 3, 1783-1788
23. Larner, J., Villar-Palasi, C., and Brown, N. (1969) Uridine diphosphate glucose: a-1, 4-glucan a-4-glucosyltransferase in heart. Two forms of the enzyme, interconversion reactions and properties. Biochim. Biophys. Acta 178, 470-479
24. Schlender, K. K., and Larner, J. (1973) Purification and properties of glycogen synthase I from skeletal muscle: two kinetic forms. Biochim. Biophys. Acta 293, 73-83
25. Rosell-Perez, M., and Larner, J. (1964) Studies on UDPG-a-glucan transglucosylase. V. Two forms of the enzyme in dog skeletal muscle and their interconversion. Biochemistry 3, 81-88
26. Walsh, D. A., Ashby, C. D., Gonzalez, C., Calkins, D., Fischer, E. H., and Krebs, E. G. (1971) Purification and characterization of a protein inhibitor of adenosine 3', 5'-monophosphate-dependent protein kinases. J. Biol. Chem. 246, 1977-1985
27. 2+-dependent glycogen synthase phosphatase (phosphoprotein phosphatase IA) from rat liver. Eur. J. Biochem. 119, 503-510
28. Tamura, S., Lynch, K. R., Larner, J., Fox, J., Yasui, A., Kikuchi, K., Suzuki, Y., and Tsuiki, S. (1989) Molecular cloning of rat type 2C (IA) protein phosphatase mRNA. Proc. Natl. Acad. Sci. U. S. A. 86, 1796-1800
29. Takeda, Y., Brewer, H. B., Jr., and Larner, J. (1975) Structural studies on rabbit muscle glycogen synthase. I. Subunit composition. J. Biol. Chem. 250, 8943-8950
30. Roach, P. J., Takeda, Y., and Larner, J. (1976) Rabbit skeletal muscle glycogen synthase. I. Relationship between phosphorylation state and kinetic properties. J. Biol. Chem. 251, 1913-1919
31. Roach, P. J., and Larner, J. (1976) Rabbit skeletal muscle glycogen synthase. II. Enzyme phosphorylation state and effector concentrations as interacting control parameters. J. Biol. Chem. 251, 1920-1925
32. Walkenbach, R. J., Hazen, R., and Larner, J. (1978) Reversible inhibition of cyclic AMP-dependent protein kinase by insulin. Mol. Cell. Biochem. 19, 31-41
33. Guinovart, J. J., Lawrence, J. C., Jr., and Larner, J. (1978) Hormonal effects on fat cell adenosine 3', 5'-monophosphate dependent protein kinase. Biochim. Biophys. Acta 539, 181-194
34. Jarett, L., and Seals, J. R. (1979) Pyruvate dehydrogenase activation in adipocyte mitochondria by an insulin-generated mediator from muscle. Science 206, 1407-1408
35. Larner, J., Galasko, G., Cheng, K., DePaoli-Roach, A. A., Huang, L., Daggy, P., and Kellogg, J. (1979) Generation by insulin of a chemical mediator that controls protein phosphorylation and dephosphorylation. Science 206, 1408-1410
36. Larner, J., Cheng, K., Schwartz, C., Kikuchi, K., Tamura, S., Creacy, S., Dubler, R., Galasko, G., Pullin, C., and Katz, M. (1982) A proteolytic mechanism for the action of insulin via oligopeptide mediator formation. Fed. Proc. 41, 2724-2729
37. Saltiel, A. R., and Cuatrecasas, P. (1986) Insulin stimulates the generation from hepatic plasma membranes of modulators derived from an inositol glycolipid. Proc. Natl. Acad. Sci. U. S. A. 83, 5793-5797
38. Larner, J., Huang, L. C., Tang, G., Suzuki, S., Schwartz, C. F., Romero, G., Roulidis, Z., Zeller, K., Shen, T. Y., Oswald, A. S., and Luttrell, L. (1988) Insulin mediators: structure and formation. Cold SpringHarb. Symp. Quant. Biol. 53, 965-971
39. Larner, J., Huang, L. C., Schwartz, C. F., Oswald, A. S., Shen, T. Y., Kinter, M., Tang, G. Z., and Zeller, K. (1988) Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphate contains galactosamine and D-chiroinositol. Biochem. Biophys. Res. Commun. 151, 1416-1426
40. Huang, L. C., Fonteles, M. C., Houston, D. B., Zhang, C., and Larner, J. (1993) Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo. Endocrinology 132, 652-657
41. Romero, G., Luttrell, L., Rogol, A., Zeller, K., Hewlett, E., and Larner, J. (1988) Phosphatidylinositol-glycan anchors of membrane proteins: potential precursors of insulin mediators. Science 240, 509-511
42. Larner, J., Price, J. D., Heimark, D., Smith, L., Rule, G., Piccariello, T., Fonteles, M. C, Pontes, C., Vale, D., and Huang, L. (2003) Isolation, structure, synthesis, and bioactivity of a novel putative insulin mediator. A galactosamine chiroinositol pseudo-disaccharide Mn chelate with insulin-like activity. J. Med. Chem. 46, 3283-3291
43. Rubenstein, A. H., Levin, N. W., and Elliott, G. A. (1962) Manganese-induced hypoglycaemia. Lancet 280, 1348-1351
44. Narayanan, C. R., Joshi, D. D., Mujumdar, A., and Dhekne, V. V. (1987) Pinitol-α new anti-diabetic compound from Bougainvillea spectabilis. Curr Sci. 56, 139-141
45. Nestler, J. E., Jakubowicz, D. J., de Vargas, A. F., Brik, C., Quintero, N., and Medina, F. (1998) Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J. Clin. Endocrinol. Metab. 83, 2001-2005
46. Brautigan, D. L., Brown, M., Grindrod, S., Chinigo, G., Kruszewski, A., Lukasik, S. M., Bushweller, J. H., Horal, M., Keller, S., Tamura, S., Heimark, D. B., Price, J., Larner, A. N., and Larner, J. (2005) Allosteric activation of protein phosphatase 2C by D-chiro-inositol-galactosamine, a putative mediator mimetic of insulin action. Biochemistry 44, 11067-11073
47. Yoshizaki, T., Maegawa, H., Egawa, K., Ugi, S., Nishio, Y., Imamura, T., Kobayashi, T., Tamura, S., Olefsky, J. M., and Kashiwagi, A. (2004) Protein phosphatase-2Ca as a positive regulator of insulin sensitivity through direct activation of phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J. Biol. Chem. 279, 22715-22726
48. Davies, S. P., Helps, N. R., Cohen, P. T. W., and Hardie, D. G. (1995) 5'-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2Ca and native bovine protein phosphatase-2Ac. FEBS Lett. 377, 421-425
49. Hans, S. K., Camara, F., Altiti, A., Martín-Montalvo, A., Brautigan, D. L., Heimark, D., Larner, J., Grindrod, S., Brown, M. L., and Mootoo, D. R. (2010) Synthesis of C-glycoside analogues of β-galactosamine- (1-4)-3-O-methyl-D-chiro-inositol and assay as activator of protein phosphatases PDHP and PP2Ca. Bioorg Med. Chem. 18, 1103-1110
50. Larner, J., Allan, G., Kessler, C., Reamer, P., Gunn, R., and Huang, L. (1998) Phosphoinositol glycan derived mediators and insulin resistance. Prospects for diagnosis and therapy. J. Basic Clin. Physiol. Pharmacol. 9, 127-137
51. Ku, B. J., Kim, H. J., and Park, K. S. (2007) The clinical study to evaluate the safety and efficacy of D-chiro-inositol in patients with type 2 diabetes. Korean J. Med. 72, 29-36
52. Nestler, J. E., Jakubowicz, D. J., Reamer, P., Gunn, R. D., and Allan, G. (1999) Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N. Engl. J. Med. 340, 1314-1320
53. Nascimento, N. R., Lessa, L. M., Kerntopf, M. R., Sousa, C. M., Alves, R. S., Queiroz, M. G., Price, J., Heimark, D. B., Larner, J., Du, X., Brownlee, M., Gow, A., Davis, C., and Fonteles, M. C. (2006) Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide. Proc. Natl. Acad. Sci. U. S. A. 103, 218-223
54. Farias, V. X., Macedo, F. H. P., Oquendo, M. B., Tome, A. R., Bao, S. N., Cintra, D. O. S., Santos, C. F., Albuquerque, A. A. C., Heimark, D. B., Larner, J., Fonteles, M. C., Leal-Cardoso, J. H., and Nascimento, N. R. F. (2011) Chronic treatment with D-chiro-inositol prevents autonomic and somatic neuropathy in STZ-induced diabetic mice. Diabetes Obes. Metab. 13, 243-250
55. Fonteles, M. C., Almeida, M. Q., and Larner, J. (2000) Antihyperglycemic effects of 3-O-methyl-D-chiro-inositol and D-chiro-inositol associated with manganese in streptozotocin diabetic rats. Horm. Metab. Res. 32, 129-132
56. Pitt, J., Thorner, M., Brautigan, D., Larner, J., and Klein, W. L. (2013) Protection against the synaptic targeting and toxicity of Alzheimer's- associated Aβ oligomers by insulin mimetic chiro-inositols. FASEB J. 27, 199-207
57. Kennington, A. S., Hill, C. R., Craig, J., Bogardus, C., Raz, I., Ortmeyer, H. K., Hansen, B. C., Romero, G., and Larner, J. (1990) Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 323, 373-378
58. Asplin, I., Galasko, G., and Larner, J. (1993) chiro-Inositol deficiency and insulin resistance: a comparison of the chiro-inositol-and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. Proc. Natl. Acad. Sci. U. S. A. 90, 5924-5928
59. Larner, J., and Craig, J. (1996) Urinary myo-inositol-to-chiro-inositol ratios and insulin resistance. Diabetes Care 19, 76-78
60. Pak, Y., Hong, Y., Kim, S., Piccariello, T., Farese, R. V., and Larner, J. (1998) In vivo chiro-inositol metabolism in the rat: a defect in chiro-inositol synthesis from myo-inositol and an increased incorporation of chiro-[3H]inositol into phospholipid in the Goto-Kakizaki (GK) rat. Mol. Cells 8, 301-309
61. Sun, T. H., Heimark, D. B., Nguygen, T., Nadler, J. L., and Larner, J. (2002) Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myoinositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls. Biochem. Biophys. Res. Commun. 293, 1092-1098
62. Shashkin, P. N., Shashkina, E. F., Fernqvist-Forbes, E., Zhou, Y. P., Grill, V., and Katz, A. (1997) Insulin mediators in man: effects of glucose ingestion and insulin resistance. Diabetologia 40, 557-563
63. Baillargeon, J.-P., Iuorno, M. J., Apridonidze, T., and Nestler, J. E. (2010) Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women with polycystic ovary syndrome. Metab. Syndr. Relat. Disord. 8, 127-136
64. Scioscia, M., Gumaa, K., Kunjara, S., Paine, M. A., Selvaggi, L. E., Rodeck, C. H., and Rademacher, T. W. (2006) Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2. J. Clin. Endocrinol. Metab. 91, 709-717
65. Lin, X., Ma, L., Gopalan, C., and Ostlund, R. E. (2009) D-chiro-Inositol is absorbed but not synthesised in rodents. Br. J. Nutr. 102, 1426-1434